ResMed | RMD - Market Capitalization


ResMed reported $32.65B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Ansell USD 3.36B 450.92M Dec/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Cochlear AUD 17.05B 2.6B Dec/2025
Cooper Companies USD 12.67B 1.44B Sep/2026
CSL USD 55.89B 20.42B Dec/2025
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Fisher Paykel Healthcare NZD 21.96B 201.12M Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Haemonetics USD 3.51B 963M Jun/2026
Idexx Laboratories USD 41.53B 3.1B Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
Intuitive Surgical USD 140.84B 22.89B Jun/2026
Medtronic USD 113.81B 4.51B Sep/2026
Philips EUR 23.09B 615.44M Jun/2026
Ramsay Health Care AUD 7.93B 537.83M Dec/2025
ResMed USD 28.27B 4.43B Jun/2026
Sigma Healthcare AUD 2.68B 2.01B Sep/2026
Steris USD 20.52B 1.16B Jun/2026
Teleflex USD 5.61B 317M Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026